570
Views
6
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma

, , , , , , & show all
Pages 627-629 | Received 13 Nov 2005, Published online: 08 Jul 2009

References

  • Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934–59
  • Kacar F, Meteoglu I, Sen S, Levi E. Primary neuroendocrine carcinoma of the mediastinum. Pathol Oncol Res 2002; 8: 200–1
  • Horie Y, Kato M. Neuroendocrine carcinoma of the posterior mediastinum: A possible primary lesion. Arch Pathol Lab Med 1999; 123: 933–6
  • Wick MR, Rosai J. Neuroendocrine neoplasm of the mediastinum. Semin Diagn Pathol 1991; 8: 35–51
  • Chinol M, Bodei L, Cremonesi M, et al. Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: The experience of the European Institute of Oncology Group. Semin Nucl Med 2002; 32: 141–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.